Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032
2010 · Journal of Translational Medicine · 224 citations
https://doi.org/10.1186/1479-5876-8-39
E
Erika von Euw
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
2.0K
Citations
19
h-index
20
i10-index
Erika von Euw is an academic researcher from University of Wisconsin–Madison. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & PARP inhibition in cancer therapy. The author has an h-index of 19, co-authored 86 publications.
ORCID: 0000-0002-3201-3311Papers by this author
worksCTLA4 blockade increases Th17 cells in patients with metastatic melanoma
2009 · Journal of Translational Medicine · 188 citations
https://doi.org/10.1186/1479-5876-7-35
Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer
2018 · Molecular Cancer Therapeutics · 104 citations
https://doi.org/10.1158/1535-7163.mct-17-0290
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
2011 · Journal of Translational Medicine · 96 citations
https://doi.org/10.1186/1479-5876-9-76
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat